Cell Biotech disclosed Friday that its third-quarter consolidated operating profit fell 9.4 percent on-year to 2.007 billion won ($1.5 million).
Revenue for the same period came in at 14.848 billion won, down 3.3 percent, according to preliminary figures.
The company swung to a net loss of 4.268 billion won in the quarter.
jiyoon436@heraldcorp.com
